Tavo-Immune Modulator (TIM) Platform


Effective regulation of T-cell and other immune cell activity is critical. However, Immune Cell activity has duality: 

1. If the activity is too weak: persistent tumor or chronic viral infection will occur; Whereas 

2. If the activity is too strong: autoimmune diseases such as rheumatoid arthritis, psoriasis, lupus, etc. will result. 

This platform is designed to modulate immune cell function to address patient’s unique condition.Two types of unique biologics are therefore created for each purpose: 

  • Chronic Viral Infections: Proof-of-Concept studies have already been conducted to confirm: molecule design and generation, component integration, target binding, and immune cell activation or suppression. Tavotek is currently working on several TIM biologics to address chronic viral infections.
  • Autoimmune Diseases: Synthetic biologics are created to neutralize / terminate autoantibody producing B-lymphocytes. Tavotek currently has two lead programs in various autoimmune diseases which affect many patients. There are several other autoimmune disease programs in planning stage at the moment as well.